about
Anticardiolipin antibodies: occurrence in Behçet's syndrome.Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitroThrombosis, abortion, cerebral disease, and the lupus anticoagulantLow molecular weight heparin in immunological recurrent abortion--the incredible curePulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodiesThrombotic thrombocytopenic purpura preceding systemic lupus erythematosusThe 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study.Subclasses of IgG anticardiolipin antibodies in patients with systemic lupus erythematosus.Postpartum spontaneous colonic perforation due to antiphospholipid syndromeAntiphospholipid antibodies: paradigm in transition.Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations.Hepatic infarction in a patient with the lupus anticoagulant.Risk factors for thrombosis in lupus patientsAnticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.The association between the lupus anticoagulant and cerebral infarction in systemic lupus erythematosus.Lupus anticoagulant associated syndrome in benign and malignant systemic disease.Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.Lung cancer, immune thrombocytopenia and the lupus inhibitorLupus anticoagulant: a clinical and laboratory study of 100 cases.Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies.Acquired coagulation inhibitor in association with Rocky Mountain spotted fever. With a review of other acquired coagulation inhibitors.Anticardiolipin antibodies: isotype distribution and phospholipid specificity.Autoimmunity and pregnancy.Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.Fluphenazine decanoate-induced cholestatic jaundice and thrombocytopenia.Adult hemolytic-uremic syndrome and bone marrow necrosis.Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy.Lupus-type "anticoagulant" in a dog with hemolysis and thrombosis.Pathogenic serum IgG anticardiolipin antibodies and the idiotypic networkClinical analysis of 125 patients with the lupus anticoagulant.Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and lupus anticoagulant.The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawalBudd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant.Phlegmasia cerulea dolens associated with the lupus anticoagulant.Antiphospholipid syndrome: linking many specialties.Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.
P2860
Q24514516-31340FFE-BB15-43E0-B7AE-54120670DA34Q24563574-8FCBB687-9882-462C-B500-ACE0FBE5F844Q24675412-C96C6125-0A1B-4C0E-AA25-9296615575D5Q28195646-830F7647-D20E-4B10-9869-33EC9B3A456BQ28340697-D4EC90D6-9B2E-44A9-8DD3-019B9959CB23Q33365302-364BF0C5-1DB2-4D72-A75C-7A3F92DCF078Q33371184-448B6843-D105-463C-AD0E-2C48C223F45DQ33376853-71E5C93A-1403-4D0D-A6EB-FAFD54C42886Q33381316-D6677797-95C2-4A02-9E78-FCF03E00EA16Q33382838-7B9D6BA9-B42C-485C-9CAC-6B78421B9B9FQ33382848-58DC8F9F-E5D3-4950-AF8E-A26630558C03Q33392824-F7C993FD-76DB-4ED8-95AC-367C0DC3A98CQ33393751-C66CF1AC-75AF-4B99-AF8D-331BD94FE2DDQ33416078-3BDE62CD-B10E-441A-AE36-4A1A55FB6328Q33417102-CAD9805B-F971-44B5-89B8-E3C8C68E0C76Q33423945-D08B9964-B405-47AF-88D3-2BEACA8A07D5Q33446426-E0DDA58D-C4AD-41B7-8228-9095564ED367Q33446982-963FE9BC-A7E3-4951-98D4-8FCEDD8CD273Q33447033-8E2835E0-5C30-4C7F-8EA2-14EABBF4B01DQ33447236-39515582-4B07-48EE-8E71-01376D3F7212Q33447286-166EDA4F-3245-455D-A880-46D998918367Q33447381-332F5D8F-DC55-49A7-97D2-48707B96858AQ33447566-6FBC73B6-A644-4ECD-866E-86A4571DDC0AQ33454700-8397435C-8563-430A-8FAA-7000BD4D1AE3Q33456927-D0711678-9F45-40AF-A3C2-E2FDFC77E224Q33458029-B3FF9BD8-FA36-4C5B-BE55-310D8E351793Q33478061-2C4C3AA1-5896-48EE-9C3E-77C3CB132740Q33478747-D63A3CB4-A591-4C10-95DD-F86DAA483402Q33478946-B22C2267-EB22-4008-A04B-331007F72E97Q33491810-1BEFEEBB-1B77-4A1C-9CEF-B8A5B92FAEA5Q33492652-BC90E376-659F-4F53-9434-D401298CC052Q33493244-FB62AC83-F1FE-438E-9D3E-3557D30C8577Q33494911-D95388A5-5C7C-4A33-A5DD-D6A68FDF3515Q33554309-69148E87-FEB2-4ECA-A6E5-82F5206602F5Q33555478-AE015E60-C887-4792-82F4-3F790F7AC960Q33556284-4650EF25-96F5-4D3F-9238-B674F4A75B0CQ33556669-1FA75B79-0F39-4B1E-9F29-4D418E36D2B7Q33558919-71403BDE-3058-45ED-B5B1-BE62A672DA62Q33561642-174D1A21-DD9C-4F44-B8A0-8BE99E9DF7A4Q33562378-6A31CE94-CF00-4FBF-80BB-3A585383228F
P2860
description
1980 nî lūn-bûn
@nan
1980 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Thrombosis in patients with the lupus anticoagulant.
@ast
Thrombosis in patients with the lupus anticoagulant.
@en
type
label
Thrombosis in patients with the lupus anticoagulant.
@ast
Thrombosis in patients with the lupus anticoagulant.
@en
prefLabel
Thrombosis in patients with the lupus anticoagulant.
@ast
Thrombosis in patients with the lupus anticoagulant.
@en
P2093
P921
P1476
Thrombosis in patients with the lupus anticoagulant.
@en
P2093
P304
P356
10.7326/0003-4819-92-2-156
P407
P433
P577
1980-02-01T00:00:00Z